Glukos som smärtlindringsmetod vid vaccinering av 18 månader gamla barn

Aim: The aim of this study was to investigate whether oral administration of two milliliters of 30 % glucose have an analgesic effect during vaccination against measles, mumps and rubella in 18-month-old children. Method: The sample group consisted of 18-month-old children who had their 18-month visit at Samariterhemmet or Eriksberg’s healthcare center (intervention group) or Flogsta healthcare center (control group) during the period of the study. The total amount of participants was 24 children; 14 children in the intervention group were observed at Samariterhemmet and Erikbergs healthcare center and 10 children were observed in the control group at Flogsta healthcare center. The study was conducted as a quantitative quasi-experimental study. During the visits the duration of the child’s crying/screaming and the parents’ perception of their child’s pain were observed and noted. Results: When measuring the duration of the child’s crying/screaming, two milliliters of 30 % glucose could not be considered to have any analgesic effect on procedure-related pain. Parents in the study group perceived their children as having more pain than the parents in the control group. Conclusion: Since this study could not show any positive analgesic effect attributed to the administration of 30 % glucose in 18-month-old children this procedure cannot be recommended for this age group. However, this study has its limitations, the low amount of participants should be considered and also the fact that eight out of ten children in the control group received a different type of vaccine (Priorix) than the rest of the sample group (MMR-II). This vaccine has been found to cause less pain than MMR-II.